Perspective Therapeutics, Inc. balance sheet

At the end of fiscal 2023, Perspective Therapeutics, Inc. had total assets of $97.9m, total liabilities of $22.7m and shareholders' equity of $75.2m. It held $9.2m in cash against $1.8m of debt: net cash of $7.5m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Perspective Therapeutics, Inc.: balance sheet, annual
Fiscal year	2011Jun 2011	2012Jun 2012	2013Jun 2013	2014Jun 2014	2015Jun 2015	2016Jun 2016	2017Jun 2017	2018Jun 2018	2019Jun 2019	2020Jun 2020	2021Jun 2021	2022Dec 2022	2023Dec 2023
Cash and equivalents	—	—	—	—	—	—	—	—	—	—	—	21	9
Receivables	1	1	1	1	1	1	1	1	1	2	2	1	1
Inventory	1	0	0	0	0	0	0	0	1	1	1	1	—
Total current assets	4	4	4	19	16	14	10	5	7	6	67	53	17
Goodwill	—	—	—	—	—	—	—	—	—	—	—	0	24
Total assets	8	8	7	27	23	18	12	7	9	9	70	58	98
Total current liabilities	1	1	1	1	1	1	1	2	1	2	2	3	16
Long-term debt	—	—	—	—	—	—	—	—	—	—	—	0	2
Total debt	0	0	0	0	0	0	0	0	0	0	0	0	2
Total liabilities	1	2	2	3	2	2	2	2	2	3	3	3	23
Shareholders' equity	6	6	5	24	21	16	11	5	8	6	67	55	75
Net debt (negative = net cash)	—	—	—	—	—	—	—	—	—	—	—	−21	−7
Shares outstanding	—	—	—	—	—	—	—	—	—	—	—	142m	28m

US$ millions unless shown otherwise. Fiscal quarters.

Perspective Therapeutics, Inc.: balance sheet, quarterly
Quarter	2022 Q1Mar 2022	2022 Q2Jun 2022	2022 Q3Sept 2022	2022 Q4Dec 2022	2023 Q1Mar 2023	2023 Q2Jun 2023	2023 Q3Sept 2023	2023 Q4Dec 2023
Receivables	2	2	1	1	—	1	2	1
Inventory	1	1	2	1	1	1	1	—
Total current assets	63	59	58	53	40	32	22	17
Goodwill	—	—	—	0	27	27	27	24
Total assets	66	64	63	58	128	120	111	98
Total current liabilities	2	2	4	3	7	9	8	16
Long-term debt	—	—	—	0	2	2	2	2
Total debt	—	—	—	0	2	2	2	2
Total liabilities	3	3	5	3	10	11	12	23
Shareholders' equity	63	61	58	55	118	109	99	75
Shares outstanding	142m	142m	142m	142m	279m	280m	281m	28m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Perspective Therapeutics, Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Perspective Therapeutics, Inc.